Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: Regulation by the protein kinase C-δ signaling

Chemico-Biological Interactions

Volumn 180, Issue 2, 2009, Pages 193-201

  Kuo, Dong Yih ^a   Yang, Shun Fa ^a   Chu, Shu Chen ^b   Chen, Chin Hsiu ^a   Hsieh, Yih Shou ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Amphetamine; Feeding; Neuropeptide Y; PKC; Superoxide dismutase

Indexed keywords

AMPHETAMINE; MESSENGER RNA; NEUROPEPTIDE Y; PROTEIN KINASE C DELTA; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; SIGNAL TRANSDUCTION;

AMPHETAMINE; ANIMALS; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; NEUROPEPTIDE Y; OXIDATIVE STRESS; PROTEIN KINASE C-DELTA; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 67349085489     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.03.013     Document Type: Article

References (67)

1. Nichols D.E. Medicinal chemistry and structure-activity relationships. In: Cho A.K., and Segal D.S. (Eds). Amphetamine and its Analogs: Psychopharmacology, Toxicology, and Abuse (1994), Academic Press, San Diego 3-41
2. Colman E. Anorectics on trial: a half century of federal regulation of prescription appetite suppressants. Ann. Intern. Med. 143 (2005) 380-385
3. Quinton M.S., and Yamamoto B.K. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J. 8 (2006) E337-E347
4. Tata D.A., and Yamamoto B.K. Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction. Addiction 102 (2007) 49-60
5. Skrinska V.A., and Gock S.B. Measurement of 3 4-MDMA and related amines in diagnostic and forensic laboratories. Clin. Lab. Sci. 18 (2005) 119-123
6. Biederman J., Spencer T.J., Wilens T.E., Weisler R.H., Read S.C., and Tulloch S.J. Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr. 10 (2005) 16-25
7. Seiden L.S., Sabol K.E., and Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 23 (1993) 639-677
8. Sulzer D., Chen T.K., Lau Y.Y., Kristensen H., Rayport S., and Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15 (1995) 4102-4108
9. Kuo D.Y. Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression. Behav. Brain Res. 147 (2003) 149-155
10. Wynne K., Stanley S., McGowan B., and Bloom S. Appetite control. J. Endocrinol. 184 (2005)
11. Woods S.C., Figlewicz D.P., Madden L., Porte Jr. D., Sipols A.J., and Seeley R.J. NPY and food intake: discrepancies in the model. Regul. Peptides 75 (1998) 403-408
12. Williams G., Bing C., Cai X.J., Harrold J.A., King P.J., and Liu X.H. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol. Behav. 74 (2001) 683-701
13. Hsieh Y.H., Yang S.F., Chiou H.L., and Kuo D.Y. Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression. Eur. J. Neurosci. 22 (2005) 715-723
14. Hsieh Y.H., Yang S.F., Chiou H.L., and Kuo D.Y. Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression. Toxicol. Appl. Pharm. 212 (2006) 99-109
15. Hsieh Y.H., Yang S.F., and Kuo D.Y. Intracerebral administration of protein kinase A (PKA) or c-AMP response element binding protein (CREB) antisense oligonucleiotide can modulate amphetamine-mediated appetite suppression in free-moving rats. Am. J. Physiol.-Endocrinol. Metab. 292 (2007) 123-131
16. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implication for cellular recognition. Nature 334 (1988) 661-665
17. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9 (1995) 484-496
18. Kikkawa U., Matsuzaki H., and Yamamoto T. Protein kinase C delta (PKC delta): activation mechanisms and functions. J. Biochem. (Tokyo) 132 (2002) 831-839
19. Yamamoto T., Matsuzaki H., Kamada S., Ono Y., and Kikkawa U. Biochemical assays for multiple activation states of protein kinase C. Nat. Protoc. 1 (2006) 2791-2795
20. Ogita K., Miyamoto S., Yamaguchi K., Koide H., Fujisawa N., Kikkawa U., Sahara S., Fukami Y., and Nishizuka Y. Isolation and characterization of delta-subspecies of protein kinase C from rat brain. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 1592-1596
21. 2-stimulated cells. J. Biochem. (Tokyo) 143 (2008) 31-38
22. Kaul S., Kanthasamy A., Kitazawa M., Anantharam V., and Kanthasamy A.G. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur. J. Neurosci. 18 (2003) 1387-1401
23. Kanthasamy A.G., Anantharam V., Zhang D., Latchoumycandane C., Jin H., Kaul S., and Kanthasamy A. A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKC delta) protects against dopaminergic neuronal degeneration in Parkinson's disease models. Free Radic. Biol. Med. 41 (2006) 1578-1589
24. Lee S.J., Kim D.C., Choi B.H., Ha H., and Kim K.T. Regulation of p53 by activated protein kinase C-delta during nitric oxide-induced dopaminergic cell death. J. Biol. Chem. 281 (2006) 2215-2224
25. Zhang D., Anantharam V., Kanthasamy A., and Kanthasamy A.G. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease. J. Pharmacol. Exp. Ther. 322 (2007) 913-922
26. Frey B.N., Valvassori S.S., Réus G.Z., Martins M.R., Petronilho F.C., Bardini K., Dal-Pizzol F., Kapczinski F., and Quevedo J. Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem. Res. 31 (2006) 699-703
27. Krasnova I.N., McCoy M.T., Ladenheim B., and Cadet J.L. cDNA array analysis of gene expression profiles in the striata of wild-type and Cu/Zn superoxide dismutase transgenic mice treated with neurotoxic doses of amphetamine. FASEB J. 16 (2002) 1379-1388
28. Way K.J., Chou E., and King G.L. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21 (2000) 181-187
29. Battaini F. Protein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol. Res. 44 (2001) 353-361
30. Zhang M., and Creese I. Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates. Neurosci. Lett. 161 (1993) 223-226
31. Ogawa S., and Pfaff D.W. Current status of antisense DNA methods in behavioral studies. Chem. Senses 23 (1998) 249-255
32. Morris B.J. Neuronal localization of neuropeptide Y gene expression in rat brain. J. Comp. Neurol. 290 (1989) 358-368
33. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
34. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. (1986), Academic Press, Sydney, Australia
35. Ritter R.C., Slusser P.G., and Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 213 (1981) 451-452
36. Liedtke C.M., and Cole T. Antisense oligodeoxynucleotide to PKC-delta blocks alpha 1-adrenergic activation of Na-K-2Cl cotransport. Am. J. Physiol. 273 (1997) C1632-C1640
37. Widnell K.L., Self D.W., Lane S.B., Russell D.S., Vaidya V., Miserendino M.J.D., Rubin C.S., Duman R.S., and Nestler E.J. Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J. Pharmacol. Exp. Ther. 276 (1996) 306-315
38. Kuo D.Y. Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats. Regul. Peptides 127 (2005) 19-26
39. Kong W.M., Stanley S., Gardiner J., Abbott C., Murphy K., Seth A., Connoley I., Ghatei M., Stephens D., and Bloom S. A role for arcuate cocaine and amphetamine-regulated transcript in hyperphagia, thermogenesis, and cold adaptation. FASEB J. 17 (2003) 1688-1690
40. Oldfield B.J., Allen A.M., Davern P., Giles M.E., and Owens N.C. Lateral hypothalamic 'command neurons' with axonal projections to regions involved in both feeding and thermogenesis. Eur. J. Neurosci. 25 (2007) 2404-2412
41. Cao G., Gardner A., and Westfall T.C. Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells). Biochem. Pharmacol. 73 (2007) 1446-1454
42. Giambalvo C.T. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes. Synapse 49 (2003) 125-133
43. Giambalvo C.T. Mechanisms underlying the effects of amphetamine on particulate PKC activity. Synapse 51 (2004) 128-139
44. Zhang D., Kanthasamy A., Yang Y., Anantharam V., and Kanthasamy A. Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. J. Neurosci. 27 (2007) 5349-5362
45. Wachira S.J., Hughes-Darden C.A., Taylor C.V., Ochillo R., and Robinson T.J. Evidence for the interaction of protein kinase C and melanocortin 3-receptor signaling pathways. Neuropeptides 37 (2003) 201-210
46. Kim R.Y., Shin S.W., Kim B.J., Lee W., and Baik J.H. Dynamic regulation of hypothalamic neuropeptide gene expression and food intake by melanocortin analogues and reversal with melanocortin-4 receptor antagonist. Biochem. Biophys. Res. Commun. 329 (2005) 1178-1185
47. Menyhert J., Wittmann G., Hrabovszky E., Keller E., Liposits Z., and Fekete C. Interconnection between orexigenic neuropeptide Y- and anorexigenic alpha-melanocyte stimulating hormone-synthesizing neuronal systems of the human hypothalamus. Brain Res. 1076 (2006) 101-105
48. Roseberry A.G., Liu H., Jackson A.C., Cai X., and Friedman J.M. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 41 (2004) 711-722
49. Seeley R.J., Drazen D.L., and Clegg D.J. The critical role of the melanocortin system in the control of energy balance. Annu. Rev. Nutr. 24 (2004) 133-149
50. Jayanthi S., Ladenheim B., and Cadet J.L. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann. NY Acad. Sci. 844 (1998) 92-102
51. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Rev. 36 (2001) 1-22
52. Asanuma M., Miyazaki I., Higashi Y., Cadet J.L., and Ogawa N. Methamphetamine-induced increase in striatal p53 DNA-binding activity is attenuated in Cu,Zn-superoxide dismutase transgenic mice. Neurosci. Lett. 325 (2002) 191-194
53. Talior I., Tennenbaum T., Kuroki T., and Eldar-Finkelman H. PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase. Am. J. Physiol.-Endocrinol. Metab. 288 (2005) E405-E411
54. Nitti M., Furfaro A.L., Traverso N., Odetti P., Storace D., Cottalasso D., Pronzato M.A., Marinari U.M., and Domenicotti C. PKC delta and NADPH oxidase in AGE-induced neuronal death. Neurosci. Lett. 416 (2007) 261-265
55. Romanova L.Y., Alexandrov I.A., Nordan R.P., Blagosklonny M.V., and Mushinski J.F. Cross-talk between protein kinase C-alpha (PKC-alpha) and -delta (PKC-delta): PKC-alpha elevates the PKC-delta protein level, altering its mRNA transcription and degradation. Biochemistry 37 (1998) 5558-5565
56. Mandil R., Ashkenazi E., Blass M., Kronfeld I., Kazimirsky G., Rosenthal G., Umansky F., Lorenzo P.S., Blumberg P.M., and Brodie C. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Res. 61 (2001) 4612-4619
57. Dempsey E.C., Newton A.C., Mochly-Rosen D., Fields A.P., Reyland M.E., Insel P.A., and Messing R.O. Protein kinase C isozymes and the regulation of diverse cell responses. Am. J. Physiol. Lung Cell Mol. Physiol. 279 (2000) L429-L438
58. Murakami M., Horowitz A., Tang S., Ware J.A., and Simons M. Protein kinase C (PKC) delta regulates PKCalpha activity in a Syndecan-4-dependent manner. J. Biol. Chem. 277 (2002) 20367-20371
59. Venugopal S.K., Devaraj S., Yang T., and Jialal I. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes 51 (2002) 3049-3054
60. Kitazawa M., Anantharam V., and Kanthasamy A.G. Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. Neuroscience 119 (2003) 945-964
61. 2-terminal kinase by hypoxia-reoxygenation. Am. J. Physiol.-Heart. Circ. Physiol. 292 (2007) H1675-H1684
62. Cubells J.F., Rayport S., Rajendran G., and Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14 (1994) 2260-2271
63. Yamamoto B.K., and Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 287 (1998) 107-114
64. Hsieh Y.S., Yang S.F., Chu S.C., Ho Y.J., Kuo C.S., and Kuo D.Y. Transcriptional interruption of cAMP response element binding protein modulates superoxide dismutase and neuropeptide Y-mediated feeding behavior in freely moving rats. J. Neurochem. 105 (2008) 1438-1449
65. Miyatake M., Narita M., Shibasaki M., Nakamura A., and Suzuki T. Glutamatergic neurotransmission and protein kinase C play a role in neuron-glia communication during the development of methamphetamine-induced psychological dependence. Eur. J. Neurosci. 22 (2005) 1476-1488
66. Narita M., Miyatake M., Shibasaki M., Tsuda M., Koizumi S., Narita M., Yajima Y., Inoue K., and Suzuki T. Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization. J. Neurochem. 93 (2005) 1383-1392
67. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254